## Abstract IGFβ1 and IGFBPβ3 may influence risk of prostate cancer through their roles in cellular growth, metabolism and apoptosis, however, epidemiologic results have been inconsistent. The role of obesity in prostate cancer risk is not clearly understood, but hyperinsulinemiaβrelated increases
Circulating Insulin-like Growth Factor (IGF)-I and IGF Binding Protein (IGFBP)-3 Levels and Postmenopausal Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort
β Scribed by Catherine Schairer; Catherine A. McCarty; Claudine Isaacs; Laura Y. Sue; Michael N. Pollak; Christine D. Berg; Regina G. Ziegler
- Book ID
- 107683239
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 170 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1868-8497
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Biologic evidence suggests substantial effect of insulinβlike growth factor (IGF)βI in mammary cell carcinogenesis. However, controversy remains regarding the association between circulating IGFβI levels and the risk of premenopausal breast cancer in epidemiologic studies. In addition,
Insulin-like growth factor-I (IGF-I) has mitogenic and anti-apoptotic properties and has been implicated in the development of breast, colorectum, prostate and lung cancer. IGF binding proteins (IGFBPs) are not only carrier proteins for IGFs but also hold a central position in IGF ligand-receptor in